ANI Pharmaceuticals CFO Stephen P. Carey Exercises Stock Options and Sells Shares

Stephen P. Carey, Senior Vice President and CFO of ANI Pharmaceuticals Inc., filed a Form 4 reporting transactions involving company stock on June 5, 2026. Carey exercised stock options for 3,312 shares at an exercise price of $49.51 per share, then immediately sold the same number of shares at $80.00 per share. The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026. Following these transactions, Carey's direct holdings of common stock decreased from 183,705 shares to 180,393 shares, while his remaining stock options decreased from 9,938 to 6,626. The stock options were part of a grant that vested 25% annually from 2018 to 2021 and expire on March 30, 2027.